Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA26014F1139· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2014· $338,223 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

DRUG BULK OREDER PROLASTIN

First action · last action
2014-01-21 · 2016-05-10
Transactions
2
First transaction's obligation
$400,000
Base + all options value (sum of deltas)
$338,223
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$400,000$0Base award · 2014-01-21 · this action $400,000 · running total $400,000Modification P00001 · 2016-05-10 · this action -$61,777 · running total $338,223
  • Base2014-01-21+$400,000= $400,000
  • Mod P000012016-05-10-$61,777= $338,223
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-01-21+$400,000$400,000DRUG BULK OREDER PROLASTIN
Mod P00001· FUNDING ONLY ACTION2016-05-10−$61,777$338,223DRUG BULK OREDER PROLASTIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26014F1139_3600_V797D30042_3600 · retrieved 2026-09-26.